BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36721901)

  • 21. CD47 expression and CD163
    Imam R; Chang Q; Black M; Yu C; Cao W
    BMC Cancer; 2021 Mar; 21(1):320. PubMed ID: 33765961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Lymph Node Metastasis and Feasibility of Endoscopic Treatment in Ulcerative Early Gastric Cancer.
    Ren MH; Qi XS; Chu YN; Yu YN; Chen YQ; Zhang P; Mao T; Tian ZB
    Ann Surg Oncol; 2021 Apr; 28(4):2407-2417. PubMed ID: 32975685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clinical Significance of Lymphovascular Invasion in Gastric Cancer.
    Fujikawa H; Koumori K; Watanabe H; Kano K; Shimoda Y; Aoyama T; Yamada T; Hiroshi T; Yamamoto N; Cho H; Shiozawa M; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
    In Vivo; 2020; 34(3):1533-1539. PubMed ID: 32354959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of Lymph Node Metastasis and Differences Between Pure and Mixed Histologic Types of Early Gastric Signet-ring Cell Carcinomas.
    Chu Y; Mao T; Li X; Jing X; Ren M; Huang Z; Zhou XB; Chen Y; Tian Z
    Am J Surg Pathol; 2020 Jul; 44(7):934-942. PubMed ID: 32149737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors of Lymph Node Metastasis in Patients with Early Pure and Mixed Signet Ring Cell Gastric Carcinomas.
    Hu Q; Dekusaah R; Cao S; Pang T; Wang Y; Zhang B; Lv Y; Zhang X; Ling T; Zhuge Y; Wang L; Zou X; Zhang W; Huang Q; Xu G
    J Cancer; 2019; 10(5):1124-1131. PubMed ID: 30854120
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor Budding Is Independently Predictive for Lymph Node Involvement in Early Gastric Cancer.
    Gulluoglu M; Yegen G; Ozluk Y; Keskin M; Dogan S; Gundogdu G; Onder S; Balik E
    Int J Surg Pathol; 2015 Aug; 23(5):349-58. PubMed ID: 25911564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma.
    Lee SH; Jee SR; Kim JH; Seol SY
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):170-4. PubMed ID: 25503738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
    Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying predictors of lymph node metastasis after endoscopic resection in patients with minute submucosal cancer of the stomach.
    Choi JY; Park YS; Jung HY; Son DH; Ahn JY; Han S; Lim H; Choi KS; Lee JH; Kim DH; Choi KD; Song HJ; Lee GH; Kim JH
    Surg Endosc; 2015 Jun; 29(6):1476-83. PubMed ID: 25249150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
    Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
    World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: a systematic review and meta-analysis.
    Hatta W; Gotoda T; Kanno T; Yuan Y; Koike T; Moayyedi P; Masamune A
    J Gastroenterol; 2020 Aug; 55(8):742-753. PubMed ID: 32277297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term oncological outcomes of submucosal manipulation during non-curative endoscopic submucosal dissection for submucosal invasive gastric cancer: a multicenter retrospective study in Japan.
    Ito H; Gotoda T; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Nakagawa M; Hatta W; Hirano M; Esaki M; Matsuda M; Ohnita K; Shimoda R; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Hayashi Y; Nakaya N; Nakamura T; Shimosegawa T
    Surg Endosc; 2018 Jan; 32(1):196-203. PubMed ID: 28639037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poorly Differentiated Carcinoma Component in Submucosal Layer Should be Considered as an Additional Criterion for Curative Endoscopic Resection of Early Gastric Cancer.
    Jung DH; Bae YS; Yoon SO; Lee YC; Kim H; Noh SH; Park H; Choi SH; Kim JH; Kim H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S772-7. PubMed ID: 26242372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining the current indications for endoscopic submucosal dissection in patients with Lauren mixed-type early gastric cancer.
    Choi J; Chung H; Kim J; Kim JL; Kim SG; Jung HC
    J Gastroenterol Hepatol; 2020 Apr; 35(4):586-592. PubMed ID: 31445508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Young Age and Risk of Lymph Node Metastasis in Differentiated Type Early Gastric Cancer.
    Pyo JH; Lee H; Min YW; Min BH; Lee JH; Kim KM; Yoo H; Kim K; Choi YH; Kim JJ; Kim S
    Ann Surg Oncol; 2018 Sep; 25(9):2713-2719. PubMed ID: 30006689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of lymph node metastasis in gastric cancer conforming to indications of endoscopic resection and pylorus-preserving gastrectomy: a single-center retrospective study.
    Yanzhang W; Guanghua L; Zhihao Z; Zhixiong W; Zhao W
    BMC Cancer; 2021 Nov; 21(1):1280. PubMed ID: 34837993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
    Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
    Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
    Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.